Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease.

Xinzhong Li, Jintao Long , Taigang He, Robert Belshaw , James Scott

    Research output: Contribution to journalArticlepeer-review


    Previous studies have evaluated gene expression in Alzheimer’s disease (AD) brains to identify mechanistic processes, but have been limited by the size of the datasets studied. Here we have implemented a novel meta-analysis approach to identify differentially expressed genes (DEGs) in published datasets comprising 450 late onset AD (LOAD) brains and 212 controls. We found 3124 DEGs, many of which were highly correlated with Braak stage and cerebral atrophy. Pathway Analysis revealed the most perturbed pathways to be (a) nitric oxide and reactive oxygen species in macrophages (NOROS), (b) NFkB and (c) mitochondrial dysfunction. NOROS was also up-regulated and mitochondrial dysfunction down-regulated, in healthy ageing subjects. Upstream regulator analysis predicted the TLR4 ligands, STAT3 and NFKBIA, for activated pathways and RICTOR for mitochondrial genes. Protein-protein interaction network analysis emphasised the role of NFKB; identified a key interaction of CLU with complement; and linked TYROBP, TREM2 and DOK3 to modulation of LPS signalling through TLR4 and to phosphatidylinositol metabolism. We suggest that NEUROD6, ZCCHC17, PPEF1 and MANBAL are potentially implicated in LOAD, with predicted links to calcium signalling and protein mannosylation. Our study demonstrates a highly injurious combination of TLR4-mediated NFKB signalling, NOROS inflammatory pathway activation and mitochondrial dysfunction in LOAD.
    Original languageEnglish
    Article number12393 (2015)
    JournalNature Scientific Reports
    Publication statusPublished - 23 Jul 2015


    Dive into the research topics of 'Integrated genomic approaches identify major pathways and upstream regulators in late onset Alzheimer's disease.'. Together they form a unique fingerprint.

    Cite this